RecruitingNot ApplicableNCT06627426

Virtual Reality for Patient Informed Consent in Neurosurgery

Virtual Reality for Patient Informed Consent in Neurosurgery - a Randomized Controlled Trial


Sponsor

University Hospital, Basel, Switzerland

Enrollment

34 participants

Start Date

Oct 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized controlled trial is to evaluate benefits of VR (virtual reality)-based patient informed consent in neurosurgery regarding subjective patient comprehension, patient-doctor relationship and anxiety.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria3

  • Patients between the age of 18 and 75
  • Surgical clipping for intracranial aneurysm, resection of vascular malformations
  • Craniotomy and Resection of intracranial tumors that can be segmented for VR

Exclusion Criteria3

  • Visual or auditory impairment with no sufficient aid
  • Patient that had VR informed consent for surgery before
  • Psychiatric illness, cognitive impairment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVR-based patient informed consent

The "intervention" group will be the on receiving VR-based patient informed consent. One surgeon from the study team will be guiding the patient through their VR model first with demonstration of the technology and the model, afterwards the patient will be enabled to use the VR system by themselves. During the whole process the patient will be able to ask questions. Depending on the planned surgery, the surgical approach as well important anatomical structures will be explained.


Locations(1)

University Hospital Basel

Basel, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06627426